Kevin Lavender - Amsurg Corp Independent Director

Director

Mr. Kevin P. Lavender is Independent Director of AmSurg Corporationration since 2004 since 2004.
Age 52
Tenure 20 years
Phone615-665-1283
Webhttp://www.amsurg.com
Lavender has served as Senior Vice President and Managing Director – Large Corporationrationrationrate and Specialized Industries of Fifth Third Bank since December 2009 and served as Senior Vice President, Corporationrationrationrate Healthcare Lending of Fifth Third Bank from December 2005 through December 2009. Prior to assuming that position, Mr. Lavender served as the Commissioner of the Tennessee Department of Financial Institutions from January 2003 to December 2005. In addition to his role as Commissioner, he served as the chairman of the National Regulatory Committee for the Conference of State Bank Supervisors and was a member of the Board of Directors. Prior to being named Commissioner, Mr. Lavender was cofounder and served as Executive Vice President of Administration and Banking for MediSphere Health Partners, Inc. from May 1996 to October 2002.

Amsurg Corp Management Efficiency

The company has return on total asset (ROA) of 6.05 % which means that it generated a profit of $6.05 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 10.0 %, meaning that it generated $10.0 on every $100 dollars invested by stockholders. Amsurg Corp's management efficiency ratios could be used to measure how well Amsurg Corp manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.61 B in total debt with debt to equity ratio (D/E) of 0.83, which is about average as compared to similar companies. Amsurg Corp 525 has a current ratio of 1.62, which is within standard range for the sector. Debt can assist Amsurg Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Amsurg Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amsurg Corp 525 sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amsurg to invest in growth at high rates of return. When we think about Amsurg Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Kathryn ONeilFranklin Street Properties
55
Lisa HookPhilip Morris International
63
Robert PoletPhilip Morris International
65
Fabien SimonKeurig Dr Pepper
46
Jun MakiharaPhilip Morris International
63
Lawrence YoungKeurig Dr Pepper
65
Peggy HebardTurning Point Brands
44
Peter HarfKeurig Dr Pepper
74
Pamela PatsleyKeurig Dr Pepper
64
AnnaLena KamenetzkyKeurig Dr Pepper
42
Ashley FrushoneTurning Point Brands
46
Gregory BaxterTurning Point Brands
67
Harold BrownPhilip Morris International
90
Simon AugustesenScandinavian Tobacco Group
N/A
Stephen UsherTurning Point Brands
54
Sergio MarchionnePhilip Morris International
65
Kenneth HoxsieFranklin Street Properties
68
Robert SingerKeurig Dr Pepper
68
Steven GeringerAddus HomeCare
72
Dirk PutKeurig Dr Pepper
59
Geoffrey GormanTurning Point Brands
61
AmSurg Corporation, through its subsidiaries, offer physiciancentric surgical center and physician services in the United States. Amsurg Corp 525 (AMSGP) is traded on NASDAQ Exchange in USA and employs 9,000 people.

Management Performance

Amsurg Corp 525 Leadership Team

Elected by the shareholders, the Amsurg Corp's board of directors comprises two types of representatives: Amsurg Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amsurg. The board's role is to monitor Amsurg Corp's management team and ensure that shareholders' interests are well served. Amsurg Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amsurg Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Popp, Independent Director
Thomas Cigarran, Co-Founder, Director and Member of Nominating and Corporate Governance Committee
Claire Gulmi, CFO, Executive VP, Secretary and Director
Kevin Lavender, Independent Director
Henry Herr, Independent Director
Robert Coward, President - Physician Services and Chief Development Officer
Phillip Clendenin, President of Ambulatory Services
Cynthia Miller, Independent Director
James Deal, Independent Director
Kevin Eastridge, Chief Accounting Officer and Sr. VP of Fin.
Christopher Holden, CEO and President and Director
Steven Geringer, Independent Chairman of the Board
John Gawaluck, Director

Amsurg Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amsurg Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Amsurg Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amsurg Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amsurg Corp will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Simon Property could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Simon Property when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Simon Property - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Simon Property Group to buy it.
The correlation of Simon Property is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Simon Property moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Simon Property Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Simon Property can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Amsurg Corp 525 information on this page should be used as a complementary analysis to other Amsurg Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Amsurg Stock

If you are still planning to invest in Amsurg Corp 525 check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amsurg Corp's history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings